purchase customization

Leave This Empty:

choose chapter to purchase

table of content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hospital Acquired Infections (HAI) Diagnostics Market Size Growth Rate by Type: 2018 VS 2022 VS 2030
1.2.2 Molecular Diagnostics Tests
1.2.3 Other In-vitro Diagnostic Tests
1.3 Market by Application
1.3.1 Global Hospital Acquired Infections (HAI) Diagnostics Market Share by Application: 2018 VS 2022 VS 2030
1.3.2 Bloodstream Infections (BSI)
1.3.3 Urinary Tract Infections (UTI)
1.3.4 Surgical Site Infections (SSI)
1.3.5 Pneumonia
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Hospital Acquired Infections (HAI) Diagnostics Market Perspective (2018-2030)
2.2 Hospital Acquired Infections (HAI) Diagnostics Growth Trends by Region
2.2.1 Hospital Acquired Infections (HAI) Diagnostics Market Size by Region: 2018 VS 2022 VS 2030
2.2.2 Hospital Acquired Infections (HAI) Diagnostics Historic Market Size by Region (2018-2023)
2.2.3 Hospital Acquired Infections (HAI) Diagnostics Forecasted Market Size by Region (2023-2030)
2.3 Hospital Acquired Infections (HAI) Diagnostics Market Dynamics
2.3.1 Hospital Acquired Infections (HAI) Diagnostics Industry Trends
2.3.2 Hospital Acquired Infections (HAI) Diagnostics Market Drivers
2.3.3 Hospital Acquired Infections (HAI) Diagnostics Market Challenges
2.3.4 Hospital Acquired Infections (HAI) Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hospital Acquired Infections (HAI) Diagnostics Players by Revenue
3.1.1 Global Top Hospital Acquired Infections (HAI) Diagnostics Players by Revenue (2018-2023)
3.1.2 Global Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global Hospital Acquired Infections (HAI) Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hospital Acquired Infections (HAI) Diagnostics Revenue
3.4 Global Hospital Acquired Infections (HAI) Diagnostics Market Concentration Ratio
3.4.1 Global Hospital Acquired Infections (HAI) Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hospital Acquired Infections (HAI) Diagnostics Revenue in 2022
3.5 Hospital Acquired Infections (HAI) Diagnostics Key Players Head office and Area Served
3.6 Key Players Hospital Acquired Infections (HAI) Diagnostics Product Solution and Service
3.7 Date of Enter into Hospital Acquired Infections (HAI) Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hospital Acquired Infections (HAI) Diagnostics Breakdown Data by Type
4.1 Global Hospital Acquired Infections (HAI) Diagnostics Historic Market Size by Type (2018-2023)
4.2 Global Hospital Acquired Infections (HAI) Diagnostics Forecasted Market Size by Type (2023-2030)
5 Hospital Acquired Infections (HAI) Diagnostics Breakdown Data by Application
5.1 Global Hospital Acquired Infections (HAI) Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global Hospital Acquired Infections (HAI) Diagnostics Forecasted Market Size by Application (2023-2030)
6 North America
6.1 North America Hospital Acquired Infections (HAI) Diagnostics Market Size (2018-2030)
6.2 North America Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2018-2023)
6.3 North America Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2023-2030)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Hospital Acquired Infections (HAI) Diagnostics Market Size (2018-2030)
7.2 Europe Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2018-2023)
7.3 Europe Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2023-2030)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hospital Acquired Infections (HAI) Diagnostics Market Size (2018-2030)
8.2 Asia-Pacific Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2018-2023)
8.3 Asia-Pacific Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2023-2030)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Hospital Acquired Infections (HAI) Diagnostics Market Size (2018-2030)
9.2 Latin America Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2018-2023)
9.3 Latin America Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2023-2030)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Market Size (2018-2030)
10.2 Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2018-2023)
10.3 Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2023-2030)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 BioM?rieux
11.1.1 BioM?rieux Company Detail
11.1.2 BioM?rieux Business Overview
11.1.3 BioM?rieux Hospital Acquired Infections (HAI) Diagnostics Introduction
11.1.4 BioM?rieux Revenue in Hospital Acquired Infections (HAI) Diagnostics Business (2018-2023)
11.1.5 BioM?rieux Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Detail
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Hospital Acquired Infections (HAI) Diagnostics Introduction
11.2.4 Abbott Laboratories Revenue in Hospital Acquired Infections (HAI) Diagnostics Business (2018-2023)
11.2.5 Abbott Laboratories Recent Development
11.3 Roche AG
11.3.1 Roche AG Company Detail
11.3.2 Roche AG Business Overview
11.3.3 Roche AG Hospital Acquired Infections (HAI) Diagnostics Introduction
11.3.4 Roche AG Revenue in Hospital Acquired Infections (HAI) Diagnostics Business (2018-2023)
11.3.5 Roche AG Recent Development
11.4 Siemens Healthcare
11.4.1 Siemens Healthcare Company Detail
11.4.2 Siemens Healthcare Business Overview
11.4.3 Siemens Healthcare Hospital Acquired Infections (HAI) Diagnostics Introduction
11.4.4 Siemens Healthcare Revenue in Hospital Acquired Infections (HAI) Diagnostics Business (2018-2023)
11.4.5 Siemens Healthcare Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details